HSBC Holdings’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
HSBC Holdings's CDNA Position: Q2 2026 in Review
HSBC Holdings increased its CareDx (CDNA) stake by 411% in Q2 2026, buying an estimated $3.44M and bringing the position to 196,250 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.
HSBC Holdings first reported a position in CDNA in Q4 2020 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- HSBC Holdings held 196,250 shares of CareDx worth $5.59M as of Q2 2026.
- HSBC Holdings bought 157,863 CareDx shares in Q2 2026, an estimated $3.44M.
- CareDx made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1179 holding.
- HSBC Holdings first reported a position in CareDx in Q4 2020 and has held it in 13 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.